share_log

HC Wainwright & Co. Reiterates Buy on Ocuphire Pharma, Maintains $20 Price Target

HC Wainwright & Co. Reiterates Buy on Ocuphire Pharma, Maintains $20 Price Target

HC Wainwright & Co.重申买入 Ocuphire Pharma,维持20美元的目标价格
Benzinga ·  2023/03/31 06:21

HC Wainwright & Co. analyst Matthew Caufield reiterates Ocuphire Pharma (NASDAQ:OCUP) with a Buy and maintains $20 price target.

HC Wainwright&Co.分析师Matthew Caufield重申Ocuphire Pharma(纳斯达克股票代码:OCUP)为Buy,并维持20美元的目标价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发